Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.
DL Porter, MS Roth, SJ Lee, C McGarigle… - Bone marrow …, 1996 - europepmc.org
Relapse remains a significant problem after allogeneic bone marrow transplantation (BMT).
For patients with relapsed chronic myelogenous leukemia (CML), infusions of donor …
For patients with relapsed chronic myelogenous leukemia (CML), infusions of donor …
Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation.
J Mehta, R Powles, S Singhal, D Tait… - Bone marrow …, 1995 - europepmc.org
Six patients with high-risk acute myeloid leukemia (AML) relapsing after allogeneic bone
marrow transplantation (BMT) were treated with interferon-alpha 2b to stimulate graft-versus …
marrow transplantation (BMT) were treated with interferon-alpha 2b to stimulate graft-versus …
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation …
WR Drobyski, CA Keever, MS Roth, S Koethe… - 1993 - ashpublications.org
Eight patients who had hematologic relapse of chronic myelogenous leukemia (CML) after
undergoing allogeneic bone marrow transplantation (BMT) were treated with leukocyte …
undergoing allogeneic bone marrow transplantation (BMT) were treated with leukocyte …
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of …
S Mackinnon, EB Papadopoulos, MH Carabasi… - 1995 - ashpublications.org
Infusions of large numbers (> 10 (8)/kg) of donor leukocytes can induce remissions in
patients with chronic myeloid leukemia (CML) who relapse after marrow transplantation. We …
patients with chronic myeloid leukemia (CML) who relapse after marrow transplantation. We …
Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow …
WR Drobyski, MS Roth, SN Thibodeau… - Bone marrow …, 1992 - europepmc.org
Donor leukocyte infusions were administered to a patient who had relapsed with chronic
myelogenous leukemia after having failed two successive HLA-matched allogeneic bone …
myelogenous leukemia after having failed two successive HLA-matched allogeneic bone …
Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation.
BM Bär, A Schattenberg, EJ Mensink… - Journal of Clinical …, 1993 - ascopubs.org
PURPOSE Treatment options for patients with chronic myeloid leukemia (CML) who relapse
after allogeneic bone marrow transplantation (BMT) are limited. Treatment with lymphocytes …
after allogeneic bone marrow transplantation (BMT) are limited. Treatment with lymphocytes …
Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.
J Szer, AP Grigg, GL Phillips… - Bone Marrow …, 1993 - europepmc.org
Four patients with acute myeloid leukaemia relapsed within 6 months of allogeneic BMT.
Three patients were treated with cytosine arabinoside and amsacrine while the fourth …
Three patients were treated with cytosine arabinoside and amsacrine while the fourth …
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation
S Giralt, J Hester, Y Huh, C Hirsch-Ginsberg, G Rondon… - 1995 - ashpublications.org
Donor lymphocyte infusions can reinduce complete remission in the majority of patients with
chronic myelogenous leukemia (CML) who relapse into chronic phase after allogeneic bone …
chronic myelogenous leukemia (CML) who relapse into chronic phase after allogeneic bone …
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party …
HJ Kolb, A Schattenberg, JM Goldman, B Hertenstein… - 1995 - ashpublications.org
The immune reactivity of allogeneic lymphocytes plays a major role in the control of
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …
leukemia after bone marrow transplantation. In patients with recurrent leukemia after marrow …
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation
A Bacigalupo, M Soracco, F Vassallo, M Abate… - Bone marrow …, 1997 - nature.com
Donor lymphocyte infusions (DLI) were given between June 1990 and March 1996 to 18
patients with chronic myeloid leukemia (CML) for the treatment of cytogenetic (n= 6) or …
patients with chronic myeloid leukemia (CML) for the treatment of cytogenetic (n= 6) or …